To investigate whether fibroblast-derived VEGF could recruit VEGFR1+ cells to growing tumours, the experiment was repeated using NEFs or IGF2-pretreated NEFs mixed with ESCC cells (KYSE150) for establishment of subcutaneous tumour xenografts. The gene discussed is IGF2; the disease is esophageal squamous cell carcinoma.